A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge | PNAS
Frontiers | Characterization of Influenza A and B Viruses Circulating in Southern China During the 2017–2018 Season
Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017–18 (PHIRST): a population cohort study - The Lancet Global Health
Jamaica on alert for influenza - PAHO/WHO | Pan American Health Organization
Influenza | The BMJ
Flu (Influenza): Causes, Symptoms, Types & Treatment
Relationship between hemagglutinin stability and influenza virus persistence after exposure to low pH or supraphysiological heating | PLOS Pathogens
Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection | Nature Communications
Understanding Flu Viruses | CDC
What Is the Incubation Period for the Flu, and When Is It Contagious?
WHO EMRO | Information resources | Influenza | Health topics
Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle | PLOS Pathogens
Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract | Nature Reviews Microbiology
Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses | Nature Communications
Management and control of communicable diseases in schools and other child care settings: systematic review on the incubation pe
COVID-19 and the Flu
COVID-19 and the Flu
SARS-CoV-2 + Flu A + Flu B + RSV - CERTEST Biotec IVD Diagnostic Products
5. Seasonal Influenza | ATrain Education
Influenza - Chapter 4 - 2020 Yellow Book | Travelers' Health | CDC
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial | Nature Medicine
Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective - ScienceDirect
Coronavirus vs. flu: How to tell the difference
The incubation period of a viral infection
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial - The Lancet Infectious Diseases
Highly Conserved Protective Epitopes on Influenza B Viruses | Science
